1. Outcome of Allogeneic Stem Cell Transplantation for Patients Transformed to Myelodysplastic Syndrome or Leukemia from Severe Aplastic Anemia: A Report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation 
Ayad Ahmed Hussein, Constantijn M. Halkes, Gérard Socié, André Tichelli, Peter A. von dem Borne, Michel N.P.M. Schaap, Robin Foa, Arnold Ganser, Carlo Dufour, Andrea Bacigalupo, Anna Locasciulli, Mahmoud Aljurf, Christina Peters, Marie Robin, Anja A. van Biezen, Liisa Volin, Theo De Witte, Judith Marsh, Jakob R. Passweg, Nicolas Kröger 
Biology of Blood and Marrow Transplantation 
Volume 20, Issue 9, Pages (September 2014)
DOI: /j.bbmt
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Survival of the 140 patients undergoing allogeneic HSCT for MDS/AML transformed from SAA.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Survival of patients undergoing HSCT with refractory disease compared with those undergoing HSCT while in any type of remission or with untreated disease (P = .002).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions